In Vivo and In Vitro Exposure to Free Fatty Acids Induce Increased Androgen Production in Animal Models: A Potential Pathogenic Factor of Polycystic Ovary Syndrome

    September 2008 in “ Fertility and Sterility ”
    Catherine Baptiste, Xiuli Ci, Lucie Chouinard, N. Gallot-Payet, André C. Carpentier, Jean-Patrice Baillargeon
    Image of study
    TLDR Free fatty acids may increase androgen production, potentially contributing to polycystic ovary syndrome.
    The document reports on two separate studies related to androgen levels in different conditions. The first study compared androgen profiles between pregnant women with gestational diabetes mellitus (GDM) (Group I, N=10) and healthy pregnant controls (Group II, N=8) in a Midwestern United States population. The results showed that women with GDM had significantly elevated levels of free testosterone, androstenedione, dihydrotestosterone, 3a-diol G, and dehydroepiandrosterone sulfate compared to healthy controls, suggesting that impaired glucose tolerance and hyperandrogenemia in pregnancy are common across diverse ethnic backgrounds. The second study examined the relationship between clinical and biochemical hyperandrogenism in 62 patients with polycystic ovary syndrome (PCOS), finding that 87% had clinical hyperandrogenism while only 51% had biochemical hyperandrogenism. The study concluded that biochemical and clinical hyperandrogenism are distinct entities in PCOS, and no androgen correlates well with clinical hyperandrogenism, acne, or hirsutism. Lastly, an animal model study suggested that exposure to free fatty acids (FFAs) in female dogs (N=6) led to increased androgen production, which could contribute to the hyperandrogenemia typical of PCOS. This effect was also observed in vitro in bovine adrenal fasciculata cells exposed to FFAs. These findings indicate that FFAs may play a role in both insulin resistance and hyperandrogenemia in PCOS.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 1000+ results

      community My Testosterone results before and after Finasteride

      in Update  149 upvotes 3 years ago
      Finasteride significantly increased testosterone levels for the user, with no major side effects except watery semen, which was resolved with zinc supplements. The user's hairline stopped receding and slightly improved.

      community risks with finasteride and dutasteride

      in Research/Science  141 upvotes 2 weeks ago
      Finasteride and dutasteride have potential risks, including post-finasteride syndrome, but are commonly used for hair loss. RU58841, minoxidil, and needling are suggested as alternatives, though all treatments carry risks.

      community Proof that finasteride messes with neurosteroids

      in Research/Science  230 upvotes 11 months ago
      Finasteride can impact neurosteroids, potentially causing depression and other side effects in some users. Despite these concerns, many continue using it for hair loss, with some switching to topical applications to mitigate side effects.

      community [25, F] [RANT] Shedding since March 2020. This just isn’t fair.

      in Female  42 upvotes 4 years ago
      User "missbloombastic" has been experiencing hair loss since 2016 and tried min, fin, multivitamins, and spiro with mixed results. Another user shares their struggle with hair loss and its impact on self-esteem, while a third user suggests checking blood tests and confirming the cause of hair loss.

      community Trying to understand finasteride side effects and post finasteride syndrome

      in Finasteride/Dutasteride  70 upvotes 4 years ago
      The conversation discusses the side effects of finasteride, including low libido and erectile dysfunction, and the possibility of these effects being permanent, known as post-finasteride syndrome (PFS). Some users report personal experiences with PFS and debate whether the condition is real, with varying opinions on the reversibility of side effects and the role of individual biology.

    Similar Research

    6 / 1000+ results
      The Clinical Management of Hirsutism

      research The Clinical Management of Hirsutism

      30 citations, April 1997 in “European journal of endocrinology”
      The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.
      Female Androgenic Alopecia

      research Female Androgenic Alopecia

      14 citations, September 1986 in “Archives of Dermatology”
      Women with low SHBG levels and a high 3a-diol G to SHBG ratio are likely to experience female pattern baldness, possibly due to a slight excess of androgens affecting sensitive hair bulbs.
      Medical Treatment Regimens of Hirsutism

      research Medical Treatment Regimens of Hirsutism

      12 citations, January 2004 in “Reproductive biomedicine online”
      Low-dose anti-androgen drugs and certain drug combinations are effective for hirsutism, and insulin sensitizers show promise, especially for those with polycystic ovarian syndrome.